Overcome the complexities of your In Vitro Diagnostic Regulation (IVDR) transition
We’re with you through the rough terrain
The IVDR transition will bring positive changes to EU regulation of medical devices and lab-developed tests. It also presents potential obstacles, which we can help you conquer quickly. With our ability to help ensure your compliance, supply consistency, validation, and scalability, we offer clarity and confidence for your IVDR transition.
Thermo Fisher Scientific is committed to support our customers and laboratories through the forthcoming IVDR transition impacting CE-IVD products but also Laboratory Developed Tests (LDTs). To avoid supply disruption during this transition, we are dedicated and actively working on IVDR-compliance of our CE-IVD products that remain relevant to the market.
Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support you.
To this end, we are running an extensive transition program.
Meet the team and learn about our innovations, products, and service solutions.
Catch up on past events to learn more about our presented symposias and product solutions.